Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2018)
Trademark/Service Mark Application, Principal Register
TEAS Plus Application
Serial Number:87331238
Filing Date:02/10/2017
NOTE: Data fields with the * are mandatory under TEAS Plus. The wording "(if applicable)" appears where the field is only mandatory under the facts of the particular
application.
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
ViiV Healthcare UK (No.4) Limited
*STREET
980 Great West Road
*CITY
Brentford, Middlesex
*COUNTRY
England
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
TW89GS
EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
*TYPE
private company limited by shares (prc)
* STATE/COUNTRY WHERE LEGALLY ORGANIZED
England
GOODS AND/OR SERVICES AND BASIS INFORMATION
*INTERNATIONAL CLASS
005
*IDENTIFICATION
Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the
treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral,
metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal,
hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
*FILING BASIS
SECTION 1(b)
*FILING BASIS
SECTION 44(d)
*FOREIGN APPLICATION NUMBER
3203091
*FOREIGN APPLICATION
COUNTRY
England
*FOREIGN FILING DATE
12/19/2016
INTENT TO
PERFECT 44(d)
At this time, the applicant intends to rely on §44(e) as a basis for registration. If ultimately the applicant does not rely on §44(e) as a basis for
registration, a valid claim of priority may be retained.
ADDITIONAL STATEMENTS INFORMATION
*TRANSLATION
(if applicable)
*TRANSLITERATION
(if applicable)
*CLAIMED PRIOR REGISTRATION
(if applicable)
*CONSENT (NAME/LIKENESS)
(if applicable)
*CONCURRENT USE CLAIM
(if applicable)
ATTORNEY INFORMATION
NAME
Christopher M. Hanes
ATTORNEY DOCKET NUMBER
82395075
FIRM NAME
GlaxoSmithKline
INTERNAL ADDRESS
LGTM, 5.5A
STREET
Five Moore Drive
CITY
Research Triangle Park
STATE
North Carolina
COUNTRY
United States
ZIP/POSTAL CODE
27709
EMAIL ADDRESS
trademarks@gsk.com
AUTHORIZED TO COMMUNICATE VIA EMAIL
Yes
OTHER APPOINTED ATTORNEY
Terence A. Dixon, Angela L. Wilson, Charles M. Atkinson
DOMESTIC REPRESENTATIVE INFORMATION
NAME
Christopher M. Hanes
FIRM NAME
GlaxoSmithKline
INTERNAL ADDRESS
LGTM, 5.5A
STREET
Five Moore Drive
CITY
Research Triangle Park
STATE
North Carolina
COUNTRY
United States
ZIP CODE
27709
EMAIL ADDRESS
trademarks@gsk.com
AUTHORIZED TO COMMUNICATE VIA EMAIL
Yes
CORRESPONDENCE INFORMATION
*NAME
Christopher M. Hanes
FIRM NAME
GlaxoSmithKline
INTERNAL ADDRESS
LGTM, 5.5A
*STREET
Five Moore Drive
*CITY
Research Triangle Park
*STATE
(Required for U.S. addresses)
North Carolina
*COUNTRY
United States
*ZIP/POSTAL CODE
27709
*EMAIL ADDRESS
trademarks@gsk.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL
Yes
FEE INFORMATION
APPLICATION FILING OPTION
TEAS Plus
NUMBER OF CLASSES
1
FEE PER CLASS
225
*TOTAL FEE PAID
225
SIGNATURE INFORMATION
* SIGNATURE
/Christopher M. Hanes/
* SIGNATORY'S NAME
Christopher M. Hanes
* SIGNATORY'S POSITION
Trademark Counsel - North Carolina bar member
SIGNATORY'S PHONE NUMBER
919-483-2723
* DATE SIGNED
02/10/2017
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2018)
Trademark/Service Mark Application, Principal Register
TEAS Plus Application
Serial Number:87331238
Filing Date:02/10/2017
To the Commissioner for Trademarks:
MARK: UNICORVIA (Standard Characters, see mark)
The mark in your application is UNICORVIA.
The applicant, ViiV Healthcare UK (No.4) Limited, a private company limited by shares (prc) legally organized under the laws of England, having an address of
980 Great West Road
Brentford, Middlesex TW89GS
England
XXXX (not authorized)
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
For specific filing basis information for each item, you must view the display within the Input Table.
International Class 005: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances
for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of
viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal,
hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services. (15 U.S.C. Section 1051(b)).
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on England application number 3203091, filed 12/19/2016.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on §44(e) as a basis for registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid
claim of priority may be retained.
The applicant's current Attorney Information:
Christopher M. Hanes and Terence A. Dixon, Angela L. Wilson, Charles M. Atkinson of GlaxoSmithKline
LGTM, 5.5A
Five Moore Drive
Research Triangle Park, North Carolina 27709
United States
trademarks@gsk.com (authorized)
The attorney docket/reference number is 82395075.
The applicant hereby appoints Christopher M. Hanes of GlaxoSmithKline
Five Moore Drive
LGTM, 5.5A
Research Triangle Park North Carolina 27709
United States
trademarks@gsk.com (authorized)
as applicant's representative upon whom notice or process in the proceedings affecting the mark may be served.
The applicant's current Correspondence Information:
Christopher M. Hanes
GlaxoSmithKline
LGTM, 5.5A
Five Moore Drive
Research Triangle Park, North Carolina 27709
trademarks@gsk.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant or the applicant's attorney, or the applicant's domestic representative at
the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent
application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Plus status and a requirement to submit an additional
processing fee of $125 per international class of goods/services.
A fee payment in the amount of $225 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /Christopher M. Hanes/ Date: 02/10/2017
Signatory's Name: Christopher M. Hanes
Signatory's Position: Trademark Counsel - North Carolina bar member
Signatory's Phone Number: 919-483-2723
Payment Sale Number: 87331238
Payment Accounting Date: 02/10/2017
Serial Number: 87331238
Internet Transmission Date: Fri Feb 10 10:17:14 EST 2017
TEAS Stamp: USPTO/FTK-XXX.XX.XX.X-201702101017142204
68-87331238-580ebe4e5f93178eb5a38837a701
451795a7e5018bcf5ee0e6923f3a3d7c2964-DA-
7175-20170208143327023727